Literature DB >> 11552899

Chronic use of non-steroidal anti-inflammatory drugs does not alter colonic mucosa of patients without diarrhoea.

L Beaugerie1, F Berenbaum, D Berrebi, J P Gendre, A Prier, G Kaplan, F P Chatelet.   

Abstract

BACKGROUND: Several types of colitis can be NSAID-induced, but whether chronic use of NSAIDs alters colonic mucosa in patients without diarrhoea is not known. PATIENTS AND METHODS: Biopsy specimens of rectal mucosa were taken in six patients with rheumatoid arthritis without diarrhoea receiving NSAIDs (group 1, n=6). Patients with rheumatoid arthritis without diarrhoea not receiving NSAIDs (group 2, n=9), and patients undergoing surveillance colonoscopy (group 3, n=23) served as controls. In all patients from the three study groups, intraepithelial lymphocyte count and apoptotic cell count were assessed, and sub-epithelial collagen band thickness was measured. Leucocyte population of lamina propria was evaluated semi-quantitatively. HLA-DR and CD25 expression of mucosal cells was appreciated by immunohistochemistry.
RESULTS: Intraepithelial lymphocyte count was in the normal range in all three group patients, and not statistically different between groups. Apoptotic epithelial cell count was not different between groups. Sub-epithelial collagen band thickness was normal in all the patients. No patient had a marked infiltration of lamina propria by leucocytes, and HLA-DR and CD25 were normally expressed in all patients.
CONCLUSION: These results from a small sample of patients suggest that patients without diarrhoea receiving NSAIDs on a long-term basis do not develop microscopic or inflammatory colitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11552899     DOI: 10.1046/j.1365-2036.2001.01059.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  3 in total

1.  Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study.

Authors:  I Etienney; L Beaugerie; C Viboud; A Flahault
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

2.  Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.

Authors:  Anne Hafer; Sigrid Krämer; Swantje Duncker; Martin Krüger; Michael P Manns; Stephan C Bischoff
Journal:  BMC Gastroenterol       Date:  2007-09-04       Impact factor: 3.067

3.  Antinociceptive Effects of Prim-O-Glucosylcimifugin in Inflammatory Nociception via Reducing Spinal COX-2.

Authors:  Liu-Qing Wu; Yu Li; Yuan-Yan Li; Shi-Hao Xu; Zong-Yong Yang; Zheng Lin; Jun Li
Journal:  Biomol Ther (Seoul)       Date:  2016-05-31       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.